Skip to main content
Clinical Trials/NCT07199036
NCT07199036CompletedNot Applicable

Clinical Application of the Effect of Respiratory Muscles Electrical Stimulation on Weaning in Patients With Difficult Weaning of the Mechanical Ventilation

Capital Medical University1 site in 1 country300 target enrollmentStarted: September 29, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
300
Locations
1
Primary Endpoint
Time to Successful Weaning (days)

Study Overview

Brief Summary

This trial evaluates whether transcutaneous diaphragmatic/phrenic nerve stimulation (TEDS), abdominal functional electrical stimulation (abFES), or their combination, accelerates and improves the quality of weaning from prolonged invasive mechanical ventilation (IMV), compared with standardized ICU care with sham stimulation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Invasive mechanical ventilation ≥21 days for PMV(at least 6 hours per day); expected ≥48 h Invasive mechanical ventilation.
  • •Eligible for standardized weaning protocol and SBT assessment. Informed consent by participant or legally authorized representative.

Exclusion Criteria

  • •Non-screenable/unstable arrhythmia or hemodynamics; refractory hypoxemia/hypercapnia.
  • •Pacemaker/ICD not shieldable; seizure disorder uncontrolled. Recent abdominal surgery or skin breakdown at electrode sites; BMI>35; pregnancy.
  • •Prone positioning; continuous deep neuromuscular blockade; investigator deems unsuitable.

Arms & Interventions

TEDS Only

Experimental

TEDS + Sham abFES

Intervention: TEDS (Transcutaneous Diaphragmatic/Phrenic Nerve Stimulation) (Device)

TEDS Only

Experimental

TEDS + Sham abFES

Intervention: Sham abFES (Device)

Combined

Experimental

TEDS + abFES

Intervention: TEDS (Transcutaneous Diaphragmatic/Phrenic Nerve Stimulation) (Device)

Control

Sham Comparator

Sham TEDS + Sham abFES + Standard Care

Intervention: Sham TEDS (Device)

Control

Sham Comparator

Sham TEDS + Sham abFES + Standard Care

Intervention: Sham abFES (Device)

abFES Only

Experimental

abFES + Sham TEDS

Intervention: abFES (Functional Electrical Stimulation of Abdominal Muscles) (Device)

abFES Only

Experimental

abFES + Sham TEDS

Intervention: Sham TEDS (Device)

Combined

Experimental

TEDS + abFES

Intervention: abFES (Functional Electrical Stimulation of Abdominal Muscles) (Device)

Outcomes

Primary Outcomes

Time to Successful Weaning (days)

Time Frame: From randomization up to Day 28

Days from randomization to first day achieving ≥48 h free from invasive mechanical ventilation (IMV).

Secondary Outcomes

  • Ventilator-Free Days to Day 28 (VFDs-28)(Day 0-28 after randomization)
  • Change in Diaphragm Thickening Fraction (TFdi) from Baseline to Day 28 (%)(Baseline to Day 28)
  • Readmission(Readmission of 3 month/6 month/ 12 month)
  • mortality(mortality of 3 month/6 month/ 12 month)
  • Incidence of pulmonary infection(Incidence of pulmonary infection of 3 months/ 6 months/ 12 months)
  • Change in Diaphragm Excursion (DE) Measured by M-mode Ultrasound from Baseline to Day 28 (cm)(Baseline (within 24 hours before randomization) and Day 28 after randomization)
  • Change in Diaphragm Thickening Fraction (TFdi) from Baseline to Day 28 (%)(Baseline to Day 28)
  • Change in Diaphragm Thickness (DT) Measured by B-mode Ultrasound from Baseline to Day 28 (mm)(Baseline to Day 28)
  • Weaning Success From Invasive Mechanical Ventilation Within 28 Days (% of Participants)(Up to Day 28 after randomization)
  • 28-Day In-hospital Cost From Randomization (CNY)(exactly 28 days)
  • Change in PEF from Baseline to Day 28 (L/min)(Baseline to Day 28)
  • Readmission(Readmission of 3 month/6 month/ 12 month)
  • mortality(mortality of 3 month/6 month/ 12 month)
  • Ventilator-Free Days to Day 28 (VFDs-28)(Day 0-28 after randomization)

Investigators

Sponsor
Capital Medical University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Yi Li

Principal Investigator

Capital Medical University

Study Sites (1)

Loading locations...

Similar Trials